AdvisorShares Psychedelics ETF

Yield per half year: 54.1%
Industry: Health & Biotech Equities

Category	Share, %	Quantity
Healthcare	47.63239	9

Exchange	Share, %	Quantity
NASDAQ	100	9

Country	Quantity	Companies
United States	4	Mind Medicine (MindMed) Inc. (share - 13.77%) Relmada Therapeutics, Inc. (share - 5.08%) Intra-Cellular Therapies, Inc. (share - 4.6%) Sage Therapeutics, Inc. (share - 3.7%)
United Kingdom	1	COMPASS Pathways plc (share - 6.72%)
Ireland	2	Alkermes plc (share - 5%) GH Research PLC (share - 4.24%)
Germany	1	Atai Life Sciences N.V. (share - 4.32%)
Canada	1	Greenbrook TMS Inc. (share - 0.2091%)

More functionality and data for company and portfolio analysis is available by subscription

Investing Port